New Insights II Inc
Lemoyne
716 State Street, Lemoyne, PA 17043
New Insights II Inc Lemoyne is an intensive outpatient and outpatient facility in Lemoyne, PA offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, Medicaid, and private insurance, with a sliding fee scale based on income.
Licenses and accreditations
- State department of healthLicensed by the state's department of health.
- State substance use treatment agencyLicensed by the state's substance use treatment agency.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Intensive outpatient treatment
- Several hours of treatment a day, several days a week, while living at home.
- Outpatient
- Regular appointments while living at home.
- Outpatient day treatment or partial hospitalization
- Day treatment or partial hospitalization: most of the day, going home at night.
- Outpatient methadone/buprenorphine or naltrexone treatment
- Methadone, buprenorphine, or naltrexone for opioid use, with counseling, without staying overnight.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
- Relapse prevention with naltrexone
- Naltrexone to help prevent relapse.
Payment
- Accepted
- Cash or self-payment; Medicaid; Private health insurance.
- Help with cost
- A sliding fee scale: the fee depends on income and other factors.
Who they serve
- Ages served
- Adults, 26 to 64; Young adults, 18 to 25.
- Sex
- Female; Male.
More details this facility reports
- Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity.
- Pharmacotherapies
- Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (extended-release, injectable); Naltrexone (oral).
- Treatment Approaches
- Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Comprehensive substance use assessment; Screening for substance use; Screening for tobacco use.
- Testing
- Breathalyzer or blood alcohol testing; Drug or alcohol urine screening.
- Transitional Services
- Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
- Education and Counseling Services
- Family counseling; Group counseling; Individual counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted in designated area.
- Facility Vaping Policy
- Vaping permitted in designated area.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.